抗真菌剤の世界市場レポート 2025年

抗真菌剤市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR9.0％で418億4,000万米ドルに成長します。予測期間の成長は、真菌の新興株、規制当局の承認、世界の健康問題、ヘルスケア支出の増加、患者の教育・啓発に起因すると考えられます。予測期間の主な動向には、研究開発、遠隔医療とeヘルス、抗真菌薬開発の進歩、共同研究、パートナーシップなどが含まれます。

真菌感染症の有病率の増加が、今後数年間の抗真菌剤市場の成長を牽引すると予想されます。真菌感染症は、体内や体上の真菌の侵入や増殖によって引き起こされる疾患です。真菌は、皮膚、爪、肺、粘膜など、身体のさまざまな部位に感染する可能性があります。真菌感染症の増加は、免疫不全者の増加、気候変動による真菌の増殖に好都合な環境の悪化、広域抗生物質の多用による自然微生物叢の破壊、不衛生、都市化、真菌感染症に罹患しやすくなる糖尿病などの慢性疾患の蔓延などの要因によるものと考えられています。抗真菌剤は、真菌の細胞壁や細胞膜を破壊したり、重要な酵素プロセスを阻害したり、真菌が重要な成分を合成する能力を阻害することによって、真菌の増殖や繁殖を阻害し、真菌の負荷を減らし、症状を緩和し、感染の拡大を防ぐことによって、真菌性疾患の治療に不可欠です。例えば、米国を拠点とする非営利団体である国際感染症学会は2024年9月、年間650万件の侵襲性真菌感染症が発生し、約380万人が死亡し、250万人（68％、範囲35～90％）がこれらの感染症に直接起因すると報告しています。その結果、真菌感染症の増加が抗真菌剤市場の成長を促進すると予想されます。

ヘルスケアインフラの拡大が抗真菌剤市場の成長を促進すると予想されます。ヘルスケアインフラには、ヘルスケアサービスの提供を促進する物理的・組織的構造、施設、システムが含まれます。真菌感染症の効果的な管理に必要不可欠な施設、システム、リソースが含まれます。例えば、2023年5月、英国の政府機関である国家統計局によると、2022年の英国のヘルスケア支出は約3,477億4,000万米ドルに達し、前年比0.7％の名目増加を反映しています。このようなヘルスケアインフラへの投資は、今後の抗真菌剤市場の成長を促進する上で重要な役割を果たすと予想されます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界抗真菌剤PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の抗真菌剤市場：成長率分析
• 世界の抗真菌剤市場の実績：規模と成長, 2019-2024
• 世界の抗真菌剤市場の予測：規模と成長, 2024-2029, 2034F
• 世界抗真菌剤総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の抗真菌剤市場薬剤の種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• エキノキャンディン
• アゾール
• ポリエン
• アリルアミン
• 世界の抗真菌剤市場：投与経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
• オーラル
• 非経口
• トピック
• 世界の抗真菌剤市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院と診療所
• 皮膚科クリニック
• 他のユーザー
• 世界の抗真菌剤市場エキノキャンディンのサブセグメンテーション（タイプ別）、実績と予測, 2019-2024, 2024-2029F, 2034F
• カスポファンギン
• ミカファンギン
• アニデュラファンギン
• 世界の抗真菌剤市場アゾールの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• フルコナゾール
• イトラコナゾール
• ボリコナゾール
• ポサコナゾール
• ケトコナゾール
• 世界の抗真菌剤市場、ポリエンの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• アムホテリシンB
• ナイスタチン
• 世界の抗真菌剤市場アリルアミンの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• テルビナフィン
• ナフチフィン

第7章 地域別・国別分析

• 世界の抗真菌剤市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の抗真菌剤市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 抗真菌剤市場：競合情勢
• 抗真菌剤市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Novartis International AG Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Sanofi S.A.
• Kramer Laboratories Inc.
• GlaxoSmithKline plc
• Gilead Sciences Inc.
• Basilea Pharmaceutica AG
• Sigma-Aldrich
• Astellas Pharma Inc.
• Janssen Pharmaceutica NV
• Zydus Cadila Healthcare Ltd.
• Teva Pharmaceutical Industries Ltd.
• Sun Pharmaceutical Industries Ltd.
• Sumitomo Dainippon Pharma Co. Ltd.
• Scynexis Inc.
• Mayne Pharma Inc.
• Cosmo Pharmaceuticals NV

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 抗真菌剤市場2029：新たな機会を提供する国
• 抗真菌剤市場2029：新たな機会を提供するセグメント
• 抗真菌剤市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Antifungal drugs are pharmaceuticals designed to detect and eradicate fungal pathogens, particularly in conditions arising from unsanitary environments. These medications, also referred to as antimycotic drugs, serve to treat and prevent fungal infections like athlete's foot, ringworm, candidiasis (thrush), and more severe systemic conditions such as cryptococcal meningitis.

The primary categories of antifungal drugs include echinocandins, azoles, polyenes, and allylamines. Echinocandins represent a novel class of antifungal medications that operate by specifically inhibiting the formation of 1,3-D-glucan, a crucial component of the fungal cell wall. Antifungals can be administered through various routes, including oral, parenteral, and topical methods, and they cater to therapeutic indications such as aspergillosis, dermatophytosis, candidiasis, among others. These drugs find applications in various sectors, including hospitals and clinics, dermatology clinics, and other user groups.

The antifungals market research report is one of a series of new reports from The Business Research Company that provides antifungals market statistics, including antifungals industry global market size, regional shares, competitors with antifungals market share, detailed antifungals market segments, market trends, and opportunities, and any further data you may need to thrive in the antifungals industry. This antifungals market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The antifungals market size has grown strongly in recent years. It will grow from $27.01 billion in 2024 to $29.67 billion in 2025 at a compound annual growth rate (CAGR) of 9.8%. The growth in the historic period can be attributed to fungal disease prevalence, aging population, healthcare infrastructure, awareness and education.

The antifungals market size is expected to see strong growth in the next few years. It will grow to $41.84 billion in 2029 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to emerging fungal strains, regulatory approvals, global health concerns, increased healthcare spending, patient education and awareness. Major trends in the forecast period include research and development, telemedicine and e-health, advancements in antifungal drug development, collaborations and partnerships.

The growing prevalence of fungal infections is expected to drive the growth of the antifungals market in the coming years. Fungal infections are diseases caused by the invasion and growth of fungi in or on the body. Fungi can affect various body parts, including the skin, nails, lungs, and mucous membranes. The rise in fungal infections is attributed to factors such as the increasing number of immunocompromised individuals, climate change creating more favorable environments for fungal growth, greater use of broad-spectrum antibiotics disrupting natural microbiomes, poor hygiene, urbanization, and the growing prevalence of chronic conditions like diabetes, which make individuals more susceptible to fungal infections. Antifungals are vital in treating fungal diseases by inhibiting the growth and reproduction of fungi, either by disrupting their cell wall or membrane, blocking essential enzymatic processes, or interfering with their ability to synthesize vital components, thus reducing fungal load, alleviating symptoms, and preventing the spread of infection. For instance, in September 2024, the International Society for Infectious Diseases, a US-based non-profit organization, reported an annual incidence of 6.5 million invasive fungal infections, leading to approximately 3.8 million deaths, with 2.5 million (68%; range 35-90%) directly attributable to these infections. As a result, the increasing occurrence of fungal infections is anticipated to fuel the growth of the antifungals market.

The expansion of healthcare infrastructure is expected to drive the growth of the antifungals market. Healthcare infrastructure includes the physical and organizational structures, facilities, and systems that facilitate the delivery of healthcare services. It encompasses the essential facilities, systems, and resources required for the effective management of fungal infections. For example, in May 2023, according to the Office for National Statistics, a UK-based government body, the healthcare spending in the UK reached approximately $347.74 billion in 2022, reflecting a nominal increase of 0.7% compared to the previous year. This investment in healthcare infrastructure is anticipated to play a significant role in propelling the growth of the antifungals market in the future.

Drug developers and manufacturers in the anti-infective drugs market are increasingly focusing on expanding their operations by strengthening various departments, including research and development, marketing, and manufacturing. They are achieving this through collaborative efforts and strategic partnerships with other companies and research institutes. These collaborations enable them to diversify their product portfolios and stay competitive in the market while increasing their revenues. Therefore, companies operating in the anti-infective drugs market should seriously consider the potential benefits of strategic collaborations. Such partnerships can help them broaden their product offerings, enhance their market presence, and ultimately drive higher revenues, ensuring their continued competitiveness in the market.

Major companies in the antifungals market are actively involved in product innovation to enhance their profitability. One notable innovation is the development of Supra Bioavailable Itraconazole, an advanced formulation of the antifungal medication itraconazole aimed at improving its bioavailability and efficacy in the treatment of fungal infections. For example, in June 2022, Apex Labs, an India-based pharmaceutical company, introduced Supra Bioavailable Itraconazole in 65 and 130 mg capsules. These capsules deliver a higher proportion (90 percent) of the active medication to the body's biological system, necessitating lower dosages. This reduction in inter-individual variability holds the potential for enhanced effectiveness in the treatment of fungal infections. Such innovations play a crucial role in strengthening a company's position and profitability in the antifungals market.

Major companies operating in the antifungals market include Pfizer Inc., Novartis International AG, Merck & Co. Inc., Bayer AG, Abbott Laboratories, Sanofi S.A., Kramer Laboratories Inc., GlaxoSmithKline PLC, Gilead Sciences Inc., Basilea Pharmaceutica AG, Sigma-Aldrich, Astellas Pharma Inc., Janssen Pharmaceutica NV, Zydus Cadila Healthcare Ltd., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Sumitomo Dainippon Pharma Co. Ltd., Scynexis Inc., Mayne Pharma Inc., Cosmo Pharmaceuticals NV, Leadiant Biosciences Inc., Glenmark Pharmaceuticals Limited, Cidara Therapeutics, MATINAS BIOPHARMA, Mylan N.V., Perrigo Company PLC, Wockhardt Ltd., Lupin Limited, Dr. Reddy's Laboratories Ltd., Torrent Pharmaceuticals Ltd., Hikma Pharmaceuticals PLC, Mayne Pharma Group Limited, Fresenius Kabi AG, Baxter International Inc., Akorn Operating Company LLC, Amphastar Pharmaceuticals Inc., Mylan Institutional LLC, West-Ward Pharmaceuticals Corp., Gland Pharma Limited, Aurobindo Pharma Limited

North America was the largest region in the drugs for antifungals market in 2024. The Middle East is expected to be the fastest-growing region in the antifungals market. The regions covered in the antifungals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the antifungals market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The antifungal market consists of sales of clotrimazole, miconazole, and ketoconazole. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Antifungals Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on antifungals market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for antifungals ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The antifungals market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Drug Type: Echinocandins; Azoles; Polyenes; Allylamines
• 2) By Route of Administration: Oral; Parenteral; Topical
• 3) By End users: Hospitals & Clinics; Dermatology clinics; Other Users

Subsegments

• 1) By Echinocandins: Caspofungin; Micafungin; Anidulafungin
• 2) By Azoles: Fluconazole; Itraconazole; Voriconazole; Posaconazole; Ketoconazole
• 3) By Polyenes: Amphotericin B; Nystatin
• 4) By Allylamines: Terbinafine; Naftifine
• Companies Mentioned: Pfizer Inc.; Novartis International AG; Merck & Co. Inc.; Bayer AG; Abbott Laboratories
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Antifungals Market Characteristics

3. Antifungals Market Trends And Strategies

4. Antifungals Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Antifungals Growth Analysis And Strategic Analysis Framework

• 5.1. Global Antifungals PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Antifungals Market Growth Rate Analysis
• 5.4. Global Antifungals Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Antifungals Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Antifungals Total Addressable Market (TAM)

6. Antifungals Market Segmentation

• 6.1. Global Antifungals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Echinocandins
• Azoles
• Polyenes
• Allylamines
• 6.2. Global Antifungals Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Parenteral
• Topical
• 6.3. Global Antifungals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals & Clinics
• Dermatology Clinics
• Other Users
• 6.4. Global Antifungals Market, Sub-Segmentation Of Echinocandins, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Caspofungin
• Micafungin
• Anidulafungin
• 6.5. Global Antifungals Market, Sub-Segmentation Of Azoles, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Fluconazole
• Itraconazole
• Voriconazole
• Posaconazole
• Ketoconazole
• 6.6. Global Antifungals Market, Sub-Segmentation Of Polyenes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Amphotericin B
• Nystatin
• 6.7. Global Antifungals Market, Sub-Segmentation Of Allylamines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Terbinafine
• Naftifine

7. Antifungals Market Regional And Country Analysis

• 7.1. Global Antifungals Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Antifungals Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Antifungals Market

• 8.1. Asia-Pacific Antifungals Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Antifungals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Antifungals Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Antifungals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Antifungals Market

• 9.1. China Antifungals Market Overview
• 9.2. China Antifungals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Antifungals Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Antifungals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Antifungals Market

• 10.1. India Antifungals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Antifungals Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Antifungals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Antifungals Market

• 11.1. Japan Antifungals Market Overview
• 11.2. Japan Antifungals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Antifungals Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Antifungals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Antifungals Market

• 12.1. Australia Antifungals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Antifungals Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Antifungals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Antifungals Market

• 13.1. Indonesia Antifungals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Antifungals Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Antifungals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Antifungals Market

• 14.1. South Korea Antifungals Market Overview
• 14.2. South Korea Antifungals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Antifungals Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Antifungals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Antifungals Market

• 15.1. Western Europe Antifungals Market Overview
• 15.2. Western Europe Antifungals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Antifungals Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Antifungals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Antifungals Market

• 16.1. UK Antifungals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Antifungals Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Antifungals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Antifungals Market

• 17.1. Germany Antifungals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Antifungals Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Antifungals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Antifungals Market

• 18.1. France Antifungals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Antifungals Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Antifungals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Antifungals Market

• 19.1. Italy Antifungals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Antifungals Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Antifungals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Antifungals Market

• 20.1. Spain Antifungals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Antifungals Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Antifungals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Antifungals Market

• 21.1. Eastern Europe Antifungals Market Overview
• 21.2. Eastern Europe Antifungals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Antifungals Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Antifungals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Antifungals Market

• 22.1. Russia Antifungals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Antifungals Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Antifungals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Antifungals Market

• 23.1. North America Antifungals Market Overview
• 23.2. North America Antifungals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Antifungals Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Antifungals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Antifungals Market

• 24.1. USA Antifungals Market Overview
• 24.2. USA Antifungals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Antifungals Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Antifungals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Antifungals Market

• 25.1. Canada Antifungals Market Overview
• 25.2. Canada Antifungals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Antifungals Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Antifungals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Antifungals Market

• 26.1. South America Antifungals Market Overview
• 26.2. South America Antifungals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Antifungals Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Antifungals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Antifungals Market

• 27.1. Brazil Antifungals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Antifungals Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Antifungals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Antifungals Market

• 28.1. Middle East Antifungals Market Overview
• 28.2. Middle East Antifungals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Antifungals Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Antifungals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Antifungals Market

• 29.1. Africa Antifungals Market Overview
• 29.2. Africa Antifungals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Antifungals Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Antifungals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Antifungals Market Competitive Landscape And Company Profiles

• 30.1. Antifungals Market Competitive Landscape
• 30.2. Antifungals Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Novartis International AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

31. Antifungals Market Other Major And Innovative Companies

• 31.1. Sanofi S.A.
• 31.2. Kramer Laboratories Inc.
• 31.3. GlaxoSmithKline plc
• 31.4. Gilead Sciences Inc.
• 31.5. Basilea Pharmaceutica AG
• 31.6. Sigma-Aldrich
• 31.7. Astellas Pharma Inc.
• 31.8. Janssen Pharmaceutica NV
• 31.9. Zydus Cadila Healthcare Ltd.
• 31.10. Teva Pharmaceutical Industries Ltd.
• 31.11. Sun Pharmaceutical Industries Ltd.
• 31.12. Sumitomo Dainippon Pharma Co. Ltd.
• 31.13. Scynexis Inc.
• 31.14. Mayne Pharma Inc.
• 31.15. Cosmo Pharmaceuticals NV

32. Global Antifungals Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Antifungals Market

34. Recent Developments In The Antifungals Market

35. Antifungals Market High Potential Countries, Segments and Strategies

• 35.1 Antifungals Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Antifungals Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Antifungals Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer